Trimb Healthcare

What Trimb Healthcare does

Karo Healthcare AB (the operating branded-consumer-healthcare vehicle referenced in the input under the Trimb Healthcare umbrella) is a Stockholm-based private company that owns and commercializes a portfolio of branded, original over-the-counter medicines and personal care products across six everyday healthcare categories: Digestive Health (Proct), Foot Health (Lamisil, Pevaryl), Skin Health (E45, Remescar), Vitamins & Mineral Supplements (Nutravita), Intimate Health (Multi-Gyn), Oral Care (Flux) and Pain Relief (Paracet). Products are sold in more than 90 countries with Europe and the Nordic region as core markets, distributed primarily through retail and pharmacy channels under an omnichannel, sales-led go-to-market model. The portfolio was significantly expanded through the 2018 acquisition of Opella from Sanofi, alongside parallel acquisitions of Bio Clin and CCS Healthcare in late 2018 and YouMedical Group in 2015, indicating an active roll-up strategy.

The company generates revenue through branded product sales across its categories, with disclosed annual revenue of €500+ million. In 2023 the group launched approximately 150 new products, demonstrating ongoing portfolio broadening. Karo Healthcare operates as part of Karo Group, a privately held holding structure with no public listing. The company employs approximately 460 colleagues across 13 countries, with employees from 40+ countries of origin, and reports that 46% of senior leaders are women. Its stated operating model is 'Scaled Entrepreneurship', organizing cross-functional 'squad teams' around brands or categories.

The business is run on a sales-led, consumer-centric commercial approach with omnichannel distribution through retail and pharmacy partners. Underlying technology is not disclosed in the input; no proprietary platforms, APIs, or AI/ML capabilities are described. Karo Healthcare also operates a long-running charitable partnership with Operation Smile (since 2018) and publishes annual Sustainability Statements, reflecting formal ESG infrastructure at the parent Karo Group level.

Name

Trimb Healthcare

Legal name

Karo Healthcare AB

Website

https://trimb.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Karo Healthcare AB (Trimb Healthcare group) is a Stockholm-based branded consumer healthcare company that owns and commercializes OTC brands across digestive, foot, skin, VMS, intimate, and pain categories, distributed across 90+ markets with Europe and the Nordics as core geographies.

Ownership category

akta.pro rank

Product category

Consumer Healthcare Products

NAICS

Food (Health) Supplement Retailers (456191)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Vitamins & Minerals (Single Nutrients) (CRADAGAB), Probiotics & Digestive Health Supplements (CRADAGAF), Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK)

Keywords

• Consumer healthcare products
• Pharmaceutical brand portfolio
• Over-the-counter medicines
• Skincare and personal care
• Vitamins and supplements

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

1. Branded Healthcare Product Sales: Owns and commercialises a range of documented and trusted brands within key categories of everyday healthcare including Digestive Health, Foot Health, Skin Health, Vitamins & Mineral Supplements, Intimate Health, and Pain Relief. Generates revenue through product sales across 90+ markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Trimb Healthcare (operating as Karo Healthcare AB) owns and commercialises a portfolio of branded, original consumer healthcare products and medicines across key everyday health categories including Digestive Health, Foot Health, Skin Health, Vitamins & Mineral Supplements, Intimate Health, Oral Care, and Pain Relief. The company sells products under established brands such as Proct, Lamisil, E45, Nutravita, Remescar, Pevaryl, Flux, Multi-Gyn, and Paracet in more than 90 countries.

Product overview

Karo Healthcare operates as a diversified consumer healthcare company that owns and commercializes a portfolio of branded, original products and medicines within key categories of everyday healthcare. The company manages multiple distinct brands across various health categories including digestive health (Proct), foot health (Lamisil), skin health (E45), vitamins and mineral supplements (Nutravita), intimate health (Multi-Gyn), oral care (Flux), and pain relief (Paracet). Karo Healthcare's products are available in more than 90 countries, with Europe and the Nordic region as core markets, generating revenue of over €500 million. The company launched approximately 150 new products in 2023 and employs around 460 colleagues across 13 countries.

Differentiator

Problem solved

Functional benefit

Brands

• Proct: Digestive Health products
• Lamisil
• E45
• Nutravita
• Remescar
• Pevaryl
• Flux
• Multi-Gyn
• Paracet

Products and services

• Proct Digestive Health brand within the Trimb Healthcare portfolio, offering products for everyday digestive wellness, available to consumers through retail and pharmacy channels.
• Lamisil Foot Health brand providing treatments for fungal infections and related conditions affecting the feet, sold to consumers across multiple markets.
• E45 Skin Health brand offering moisturizing and skincare products for everyday skin care needs, distributed via retail and pharmacy channels.
• Nutravita Vitamins and Mineral Supplements (VMS) brand offering nutritional supplements for health and wellness, sold to consumers.
• Remescar Skin Health brand offering products for various skin concerns, available to everyday consumers through retail and pharmacy channels.
• Pevaryl Foot Health brand offering antifungal treatments for various skin conditions, sold to consumers in multiple markets.
• Flux Oral care brand offering fluoride products for oral health, available to consumers in retail and pharmacy channels.
• Multi-Gyn Intimate Health brand offering products for vaginal and intimate care, sold to consumers through retail and pharmacy channels.
• Paracet Pain relief brand offering paracetamol-based products for everyday pain management, available to consumers.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Operation SmileminorOthers · 1 January 2018Karo Healthcare has supported Operation Smile since 2018. Operation Smile performs approximately 15,000 surgeries per year for children with cleft lip or palate. This partnership aligns with Karo's purpose of smart choices for everyday healthcare. Details are available in their Sustainability Report.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Opella: Opella is Sanofi's consumer healthcare unit (acquired by CD&R in 2024), operating brands such as Doliprane, Allegra, and Dulcolax. Direct peer — both own branded European OTC portfolios; Karo actually acquired Opella's consumer health portfolio from Sanofi in 2018.
• Perrigo Company: Perrigo is a US-listed consumer self-care company owning store-brand and branded OTC products across Europe and the US. Comparable as a branded and private-label OTC supplier with European retail exposure similar to Karo.
• STADA Arzneimittel: STADA is a European-focused generic and consumer healthcare company owned by Bain and Cinven, with brands like Grippostad and Ladival. Directly comparable as a privately-held European mid-sized branded consumer healthcare platform.
• Prestige Consumer Healthcare: Prestige Consumer Healthcare is a US-listed company that acquires and markets branded OTC and personal care products (BC Powder, Clear Eyes, Monistat). Highly comparable mid-sized platform strategy of buying and growing niche OTC brands.
• Dr. Wolff Group: Dr. Wolff Group is a German family-owned consumer healthcare company with brands like Alpecin (hair care) and Linola (skincare). Comparable as a privately-held European mid-sized branded consumer healthcare company with category-specialist brands.

Broad incumbents

• Haleon: Haleon is the largest pure-play consumer healthcare company globally (spun out of GSK in 2022), owning brands like Advil, Centrum, Voltaren, and Panadol. Comparable as a global branded OTC and VMS portfolio operator, though materially larger than Karo Healthcare.
• Bayer Consumer Health: Bayer's Consumer Health division owns brands like Aspirin, Bepanthen, Canesten, and Elevit — directly overlapping Karo's categories (foot health/antifungal with Canesten, skin health with Bepanthen). A much larger incumbent with overlapping therapeutic areas.
• Kenvue: Kenvue is the Johnson & Johnson Consumer Health spin-off owning brands like Neutrogena, Aveeno, Tylenol, and Listerine. Overlaps Karo's skin health (E45, Remescar), pain relief (Paracet), and oral care (Flux) categories at much greater scale.
• Church & Dwight: Church & Dwight owns consumer healthcare and personal care brands including Orajel, First Response, Batiste, and Nair. Comparable as a multi-brand consumer health/personal care operator, though with US-centric footprint.

Regional players

• Almirall: Almirall is a Spanish dermatology-focused pharmaceutical company with consumer-leaning OTC brands in skin care. Comparable as a European branded healthcare operator focused on dermatology, overlapping with Karo's E45 and Remescar franchises.

Market position

Strengths5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/karo-pharma-ab
• Xx.com/TrimbMENA

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trimb Healthcare